01.06.2022 • NewsChemours

Chemours Considers Ionomers Expansion

Chemours, the former DuPont chemicals business, is looking at investing in additional ionomers capacity to support growing demand into water electrolysis and fuel cell technology. The company is currently considering potential locations in the US and Europe with, it said, an eye to local community engagement and collaboration.

“The hydrogen economy demand is growing exponentially and our products are truly at its core,” said Denise Dignam, president of Advanced Performance Materials. “To meet this demand requires private/public partnerships with the right partners—partners that will be an asset to the community—responsible. And, we believe Chemours is who communities, regions, and countries should look to in order to deliver capacity necessary to achieve clean energy while maintaining a focus on protecting human health and the environment.”

The investment will be focused on ionomers that support the Nafion platform. Nafion ion exchange membranes provide a clean energy solution through water electrolysis, creating green hydrogen from renewable power. Fuel cells—another Nafion membrane application—convert hydrogen to electricity, an alternative to carbon-based energy sources.

Author: Elaine Burridge, Freelance Journalist

 

(c) Chemours
(c) Chemours

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.